Image by Solera
                February 13, 2018 | By Solera

                Novartis Gains U.S. Approval For Glatopa For Multiple Sclerosis

                Novartis’s Sandoz division has won U.S. approval for a larger dose of its Glatops drug for multiple sclerosis (MS).

                Click Here to view the original article at Specialty Pharmacy Times

                A smaller focus to make a much larger impact. Our goal is to deliver on every promise we make

                Our Mission

                Learn More